Nissan Chemical Corporation [4021.T]
TOKYO, Apr 28 (Pulse News Wire) – Nissan Chemical Corporation (4021.T) decided to amend its equity-based compensation plan, known as the Board Benefit Trust (BBT), during today's board meeting. The amendments aim to enhance alignment between executive remuneration and company performance, increasing the stock award ratio from 7% to 20%.
The revised plan also updates key performance indicators to focus more on relative TSR compared to industry peers and ROE metrics. Under the amended plan, the annual cap on grant points for executives will increase to up to 162,700 points per fiscal year, with a limit of ¥2.500 billion to be contributed to the trust annually starting from the fiscal year ending March 2026 through March 2028.
Additionally, the company plans to seek shareholder approval for these changes at its ordinary general meeting scheduled for June 25, 2026. The updated scheme includes adjustments to the number of shares acquired by the trust based on contributions made during each three-year cycle, ensuring a balance between cash and share allocations within set limits.
Detailed implementation specifics will be disclosed promptly upon decision-making.
🟡 Confidence: Standard AI-translated content.